Herantis Pharma Oyj Balance Sheet Health
Financial Health criteria checks 5/6
Herantis Pharma Oyj has a total shareholder equity of €4.7M and total debt of €34.8K, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are €6.7M and €2.0M respectively. Herantis Pharma Oyj's EBIT is €154.4K making its interest coverage ratio -9.9. It has cash and short-term investments of €6.5M.
Key information
0.7%
Debt to equity ratio
€34.82k
Debt
Interest coverage ratio | -9.9x |
Cash | €6.49m |
Equity | €4.73m |
Total liabilities | €2.02m |
Total assets | €6.75m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: HRTIS's short term assets (€6.7M) exceed its short term liabilities (€2.0M).
Long Term Liabilities: HRTIS's short term assets (€6.7M) exceed its long term liabilities (€29.8K).
Debt to Equity History and Analysis
Debt Level: HRTIS has more cash than its total debt.
Reducing Debt: HRTIS had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: HRTIS's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: HRTIS earns more interest than it pays, so coverage of interest payments is not a concern.